Merck Eyes $32 Billion Revolution Medicines Deal in Biggest Biotech Bet Since Seagen
Merck is in talks to acquire cancer-focused biotech Revolution Medicines for up to $32 billion as it races to replace Keytruda revenue before the 2028 patent cliff.
1312 articles found for "investing"
Peter Navarro's Trade Legacy on the Line as Supreme Court Prepares January 14 Tariff Ruling
The architect of Trump's 'Liberation Day' tariffs defends his policy as the Supreme Court prepares to rule on January 14 whether the president exceeded emergency powers in imposing sweeping duties.
TSMC Earnings Countdown: Goldman's 35% Target Raise Signals the AI Chip Boom Is Just Beginning
As Taiwan Semiconductor prepares to report January 15 earnings, Goldman Sachs has raised its price target by 35%, citing a 'multi-year AI growth engine' and $150 billion in planned capital spending.
Trump Says Fed Chair Decision Is Made: The 'Two Kevins' Race for America's Most Powerful Economic Job
President Trump confirms he has chosen Jerome Powell's replacement as Federal Reserve Chair, with Kevin Hassett and Kevin Warsh emerging as the top contenders for the January announcement.
China Vanke's Near-Default Exposes the Fragility of the World's Largest Property Market
China Vanke, once the country's largest homebuilder, narrowly avoided a $284 million default last week. The close call exposes the ongoing fragility of China's property sector.
Energy's Hidden AI Play: Why SLB and Oil Services Are Surging on Data Center Demand
Oil services giant SLB has surged 14% to start 2026 as investors recognize energy companies' role in powering AI data centers. Here's why the rally may continue.
Bitcoin ETFs Bleed $1.1 Billion in Three Days as Crypto Fear Index Flashes Warning
Spot Bitcoin ETFs have shed $1.1 billion in three trading days, nearly erasing 2026 gains as the Crypto Fear and Greed Index slides toward the fear zone.
Bessent Calls Fed Rate Cuts the 'Missing Ingredient' for Economic Growth
Treasury Secretary Scott Bessent urges the Federal Reserve to continue cutting interest rates, calling lower borrowing costs the key to unleashing stronger growth.
Goldman Sachs Forecasts 2.6% GDP Growth for 2026: The Bull Case for the US Economy
Goldman Sachs predicts the US economy will grow 2.6% in 2026, outpacing consensus by 0.6 percentage points. Tax cuts, Fed rate reductions, and reduced tariff drag are driving optimism.
BlackRock Says Retail Crypto Access Is 'Still So Early': The Bullish Case for Bitcoin ETFs in 2026
BlackRock's Jay Jacobs argues that retail investor access to Bitcoin through ETFs is just beginning. With $287 million in single-day inflows, the crypto giant sees 2026 as pivotal.
Tesla's 2025 Delivery Decline Raises Stakes for Robotaxi Pivot in 2026
Tesla delivered 1.63 million vehicles in 2025, marking an 8.5% annual decline. With EV sales stalling, the company's robotaxi and Optimus bets become increasingly critical.
Moderna's Flu Vaccine Filing Sparks 19% Rally: Can mRNA Technology Reinvent the Shot?
Moderna stock surges 19% in the first week of 2026 after filing for regulatory approval of its mRNA-based flu vaccine. Here's what investors need to know about the company's pivot.